A Study to Assess the Safety and Efficacy of the of the Gastric-retentive AP-CD/LD in Advanced Parkinson's Patients

Status unconfirmed · Phase 3 · Has a placebo group

Conditions studied: Parkinson's Disease

In brief

The purpose of this study is to determine whether the gastric retentive Accordion Pill™ Carbidopa/Levodopa (AP-CD/LD) is more effective than the commercially available immediate release Carbidopa/Levodopa in reducing motor fluctuations such as "off time" in advanced Parkinson's Disease patients.

Key facts

Study ID
NCT02605434
Run by
Intec Pharma Ltd.
People needed
420
Starts
2016-03-01
Expected to finish
2019-12-01
Last updated by the study team
2019-08-08

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.